Anti-depressant use by aircrew: modulation of higher nervous function and the sleep-wake continuum.
The use of anti-depressants by aircrew raises clinical and operational issues. In this commentary the importance of a multi-disciplinary approach to the decision-making process is emphasized.
Nicholson
Anthony N
AN
Division of Biomedical Sciences, King's College, Guy's Campus, London Bridge, London SE1 9RT, UK. nicholsona@btopenworld.com
D000337:Aerospace Medicine; D000401:Aircraft; D000928:Antidepressive Agents / Q000009:adverse effects*; D002490:Central Nervous System / Q000187:drug effects*; D004784:Environmental Monitoring; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D012890:Sleep / Q000187:drug effects*; D014851:Wakefulness / Q000187:drug effects*
D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors